FDA Investigator Sarah Adella Fave
Sarah Adella Fave has inspections in 2 countries as of 17 Feb 2022. Sarah Adella Fave has collaborated with a combinined 1350 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
17 Feb 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adetutu M Gidado,
Alberto A Viciedo,
Allen Lou,
Amy L Singer,
Amy M Cramer,
Ana S Cabrera,
Ann Marie Montemurro,
Annemarie Bodnar,
Atul J Agrawal,
Barbara J Wilimczyk,
Barbara Jwilimczyk Macri,
Barbara L Rellahan, PhD,
Cara M Minelli,
Constantin Y Philopoulos,
Daniel J Grabicki,
Dawn L Wydner,
Deborah B Nixon,
Doreen P Gubbay,
Dorothy J Denes,
Douglas C Kovacs,
Dr. Zhou Chen (nmi), MD PhD,
Edmund F Mrak, Jr,
Emest F Bizjak,
Emmanuel J Ramos,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Frederick Razzaghi,
Helen B Ricalde,
Helen Verdel,
Jacqueline Mdiaz Albertini,
James A Liubicich,
Jean M Kelahan,
Jose M Cayuela,
Joseph F Mcginnis, RPh,
Joy Rkozlowski Klena,
Justine Tomasso,
Karen E D'orazio,
Kelli F Dobilas,
Kevin P Foley,
Kinh Q Mac,
Ko U Min,
Kristy A Zielny,
Lata C Mathew, PhD,
Li Li,
Liatte Kreuger, PharmD,
Luis A Dasta,
Marea K Harmon,
Margaret M Sands,
Maria Estrella,
Melba T Rivera,
Melba Trivera Clavell,
Meredith L Sheridan,
Meyer J Slobotsky,
Michael Serrano,
Mina D Ahmadi,
Monika Borkowska,
Nancy L Rolli,
Nancy M Espinal,
Nicholas A Violand,
Niketa Patel,
Niraj Mehta,
Paul L Bellamy,
Peter R Lenahan,
Prabhu P Raju,
Regina T Brown,
Robin P Mathew,
Russell J Glapion,
Sandra Kershaw,
Shirley H Isbill,
Sidney B Priesmeyer,
Sinai Davis,
Stephen J Mottola,
Tara G Bizjak,
Tara R Gooen,
Thomas J Arista,
Wayne J Meyer
Sarah Adella Fave's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| April, 2000 | EIR | Hikma Injectables USA Inc. - EIR, 2000-04-12 |
| April, 2000 | EIR | Cosmetic Essence Innovations - EIR, 2000-04-24 |
| March, 2000 | EIR | Guardian Drug Company - EIR, 2000-03-30 |
| February, 2000 | EIR | CorePharma, LLC - EIR, 2000-02-10 |
| January, 2000 | FDA 483 | Med Prep Consulting, Inc. - Form 483, 2000-01-19 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more